B-421a-006 is a 24-month, double-masked, randomized, sham-controlled, multicenter study to evaluate the safety, tolerability, and efficacy of ultevursen in subjects with RP due to mutations in exon 13 of the USH2A gene.
Kimberly Stepien
Drs. Melanie Schmitt and Kimberly Stepien Awarded John W. and Helen Doolittle Professorship
Melanie Schmitt, MD, pediatric ophthalmology and adult strabismus specialist, and Kimberly Stepien, MD, retina specialist and co-vice chair of clinical affairs, have been jointly awarded the John W. and Helen Doolittle Professorship. Drs. Schmitt and …